Augur Signals: News Feed

Report Archive – January 2026

Augur Signals: News Feed
Software - Infrastructure , Technology , Alert

AiRWA Inc.: Zhou Hongyu Buys $1,861,400 in Stock

  • Acquired: Non-Derivative
AiRWA Inc.: Zhou Hongyu Buys $1,861,400 in Stock

On January 12, 2026, Zhou Hongyu, a Director at AiRWA Inc., purchased stock worth $1,861,400. This increased his holdings by 86.87% to 1,601,489 shares, reflecting confidence in the company. AiRWA Inc. is undervalued with a P/E ratio of 0.26, and increased trading volume suggests investor interest. Despite overbought RSI at 71.72, insider buying could raise the price to 1.40 short-term, though financial instability may limit growth to 1.20. Predicted prices are 1.34 in 5 days and 1.28 in 4 weeks.

Software - Application , Technology , Alert

Sprout Social, Inc.: Insider Ryan Paul Barretto Buys $1.0M Worth of Shares

  • Acquired: Non-Derivative
Sprout Social, Inc.: Insider Ryan Paul Barretto Buys $1.0M Worth of Shares
Ryan Paul Barretto, CEO of Sprout Social, Inc., purchased shares worth $1.0M, increasing his stake by 12.03% to 875,256 shares. Sprout Social shows a forward P/E ratio of 11.28, suggesting undervaluation. Recent trading volumes are low, and the stock moderately correlates with the Nasdaq Composite, which is in a bullish trend. Despite potential short-term gains, financial challenges like a negative Enterprise to EBITDA ratio indicate risks. Shares trade on NCM under ticker SPT.
Medical Instruments & Supplies , Healthcare , After action review

Impact Of Insider Trading Signal On Lucyd, Inc: A Retrospective Analysis - One Day After The Signal

  • Acquired: Non-Derivative
Impact Of Insider Trading Signal On Lucyd, Inc: A Retrospective Analysis - One Day After The Signal
On January 12, 2026, a key insider trading signal was issued for Lucyd, Inc after Gross Harrison R., the CEO, purchased $2,400 in stock. This increased his holdings by 13.98%, boosting market interest. The stock opened at $1.64 on January 13 and peaked at $1.7275, a 5.34% rise, closing at $1.6916. Trading volume surged to 173,728,400 shares, indicating strong market response. Despite the positive short-term impact, long-term effects remain uncertain due to mixed signals and valuation concerns.
Software - Application , Technology , After action review

The Ripple Effect Of Insider Trading: A Case Study On Ibotta, Inc. - One Day After The Signal

  • Acquired: Non-Derivative
The Ripple Effect Of Insider Trading: A Case Study On Ibotta, Inc. - One Day After The Signal
On January 12, 2026, insider trading by Christopher J Riedy of Ibotta, Inc. led to a notable market reaction. His purchase of shares worth $6.07M resulted in a 2.27% increase in his stake, causing Ibotta, Inc.'s stock to rise from $21.83 to a high of $22.68 by January 13, 2026. Analysts view the move as strategic yet caution against potential declines due to bearish trends. The event underscores the impact of insider actions on market dynamics.
Capital Markets , Financial Services , After action review

The Ripple Effect Of Insider Trading On Mawson Infrastructure Group Inc. - Two Days After The Signal

  • Acquired: Non-Derivative
The Ripple Effect Of Insider Trading On Mawson Infrastructure Group Inc. - Two Days After The Signal
The insider trading event on January 12, 2026, involving Endeavor Blockchain, LLC and Mawson Infrastructure Group Inc. led to significant market reactions. Endeavor Blockchain, LLC acquired shares worth $819,081, boosting confidence in Mawson Infrastructure Group Inc. This action resulted in a nearly 20% stock price increase, closing at $4.475 on January 13, 2026. The insider trading was a "Win," reflecting a strong belief in the company's potential, despite some bearish indicators.
Packaged Foods , Consumer Defensive , Alert

Clene Inc.'s David J Matlin Buys $216,664 in Stock

  • Acquired: Non-Derivative
Clene Inc.'s David J Matlin Buys $216,664 in Stock
On January 13, 2026, David J Matlin, a Director at Clene Inc., purchased stock worth $216,664, increasing his holdings by 7.5%. This transaction, executed on the NCM exchange, highlights his confidence in the company's growth. Despite Clene Inc.'s current negative P/E ratio and market volatility, insider buying suggests potential for future price stabilization. Predicted prices are $4.85 in 5 days and $5.20 in 4 weeks.
Biotechnology , Healthcare , Alert

Aktis Oncology: Vida Ventures II, LLC Buys $15M Worth of Shares

  • Acquired: Non-Derivative
Vida Ventures II, LLC, a significant stakeholder in Aktis Oncology, Inc., has shown confidence through a net buying of $15M over the past year, reflecting a bullish outlook. Their recent 17.3% stake increase was reported on NMS under ticker AKTS. Despite a high price-to-sales ratio of 211.6, Aktis Oncology is seen as undervalued, with a closing price of $21.75. Short-term predictions suggest a rise to $23.00, though mid-term gains may cap at $22.50 due to profitability concerns.
Medical Instruments & Supplies , Healthcare , Alert

Lucyd, Inc: Gross Harrison R. Buys $2,400 in Stock

  • Acquired: Non-Derivative
Gross Harrison R., CEO of Lucyd, Inc, purchased $2,400 in stock, increasing his holdings by 13.98% to 12,233 shares. Despite a negative Forward P/E, the company's Price to Sales ratio of 3.49 suggests undervaluation. Trading volume peaked at 173,728,400 shares. High RSI indicates potential gains with a short-term target of 1.85, though MACD trends advise caution. Predicted price in 4 weeks is 1.70.
Asset Management , Financial Services , Alert

NXG NextGen Infrastructure Income Fund: Nelson Blake Buys $16.5k in Shares

  • Acquired: Non-Derivative
On January 8, 2026, Nelson Blake, CFO of NXG NextGen Infrastructure Income Fund, purchased shares worth $16,500. This increased his shares by 65.2%, reflecting confidence in the company's prospects. NXG is undervalued with a P/E ratio of 6.21 and stable trading volumes. The market shows bullish indicators, suggesting potential price increases, with predicted prices of 51.2 in 5 days and 52.0 in 4 weeks.
Software - Application , Technology , Alert

Insider Trading Alert: Ibotta, Inc.'s Christopher J Riedy Buys $6.07M in Shares

  • Acquired: Non-Derivative
Insider Trading Alert: Ibotta, Inc.'s Christopher J Riedy Buys $6.07M in Shares
On January 8, 2026, Christopher J Riedy, Chief Revenue Officer of Ibotta, Inc., purchased shares worth $6.07 million on the New York Stock Exchange. This increased his stake by 2.27%. Ibotta, Inc. has a P/E of 7.14, indicating potential undervaluation compared to peers. Insider activity and valuation suggest possible upside with a price target of 23.50, despite bearish MACD trends. The stock's weak market correlation highlights company-specific dynamics.

Back

Pages total: 12

Calendar